PTPA and intestinal neoplasm: To investigate the cell origin of intestinal tumor, we first combined treatment with carcinogen 7,12-dimethylbenzanthracene (DMBA) that has previously been known to induce rodent s in the presence of 1,2-dimethyl-hydrazine [22] and PP2A inhibition via okadaic acid (OA) treatment or genetic deficiency.